Balyasny Asset Management »

Prime Medicine shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $62k 12k 5.14

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Prime Medicine

Alphabet
Vanguard Group
ARK Investment Management
BlackRock
BlackRock
T. Rowe Price Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
MWG Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Vestal Point Capital
Baker Bros. Advisors

View all funds holding Prime Medicine